Animal models of ovarian cancer

Reproductive Biology and Endocrinology

Volumn 1, Issue , 2003, Pages

  Vanderhyden, Barbara C ^a,b   Shaw, Tanya J ^a   Ethier, Jean François ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CARCINOGEN; ENVIRONMENTAL CHEMICAL; ESTRADIOL; ESTROGEN RECEPTOR; ETHYLNITROSOUREA; GONADORELIN RECEPTOR; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN; SCATTER FACTOR; STEROID HORMONE; STEROID RECEPTOR; TUMOR PROMOTER; TUMOR SUPPRESSOR PROTEIN; HORMONE;

ANIMAL MODEL; CANCER RISK; CARCINOGENESIS; EPITHELIUM CELL; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ENGINEERING; GERM CELL; GONADOTROPIN RELEASE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; OVARY CANCER; OVULATION; RAT; RETROSPECTIVE STUDY; REVIEW; STEROIDOGENESIS; TUMOR XENOGRAFT; ANIMAL; C3H MOUSE; CANCER TRANSPLANTATION; CELL TRANSFORMATION; CHICKEN; DRUG SCREENING; EXPERIMENTAL NEOPLASM; GENETICS; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; RABBIT; SHEEP; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; TRANSGENIC ANIMAL; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARCINOGENS, ENVIRONMENTAL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; EPITHELIAL CELLS; FEMALE; HORMONES; HUMANS; MICE; MICE, INBRED C3H; MODELS, ANIMAL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OVARIAN NEOPLASMS; OVULATION; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SHEEP; SPECIES SPECIFICITY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 4344669879     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-1-67     Document Type: Review

References (107)

1. Fredrickson TN: Ovarian tumors of the hen. Environ Health Perspect 1987, 73:35-51.
2. Tillmann T, Kamino K, Mohr U: Incidence and spectrum of spontaneous neoplasms in male and female CBA/J mice. Exp Toxicol Pathol 2000, 52:221-225.
3. Walsh KM, Poteracki J: Spontaneous neoplasms in control Wistar rats. Fundam Appl Toxicol 1994, 22:65-72.
4. Gregson RL, Lewis DJ, Abbott DP: Spontaneous ovarian neoplasms of the laboratory rat. Vet Pathol 1984, 21:292-299.
5. Liebelt AG, Sass B, Lombard LS: Mouse ovarian tumors - a review including classification and induction of neoplastic lesions and description of several previously unreported types. J Exp Pathol 1987, 3:115-145.
6. Beamer WG, Hoppe PC, Whitten WK: Spontaneous malignant granulosa cell tumors in ovaries of young SWR mice. Cancer Res 1985, 45:5575-5581.
7. Tennent BJ, Shultz KL, Beamer WG: Genetic susceptibility for C19 androgen induction of ovarian granulosa cell tumorigenesis in SWXJ strains of mice. Cancer Res 1993, 53:1059-1063.
8. Eppig JJ, Wigglesworth K, Varnum DS, Nadeau JH: Genetic regulation of traits essential for spontaneous ovarian teratocarcinogenesis in strain LT/Sv mice: aberrant meiotic cell cycle, oocyte activation, and parthenogenetic development. Cancer Res 1996, 56:5047-5054.
9. Colledge WH, Carlton MB, Udy GB, Evans MJ: Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature 1994, 370:65-68.
10. Hashimoto N, Watanabe N, Furuta Y, Tamemoto H, Sagata N, Yokoyama M, Okazaki K, Nagayoshi M, Takeda N, Ikawa Y, et al.: Parthenogenetic activation of oocytes in c-mos-deficient mice. Nature 1994, 370:68-71.
11. St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J, Xu T: Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 1999, 21:182-186.
12. Weiss NS, Homonchuk T, Young JLJ: Incidence of the histologic types of ovarian cancer: the US Third National Cancer Survey, 1969-1971. Gynecol Oncol 1977, 5:161-167.
13. Papadaki L, Beilby JO: The fine structure of the surface epithelium of the human ovary. J Cell Sci 1971, 8:445-465.
14. Blaustein A, Lee H: Surface cells of the ovary and pelvic peritoneum: a histochemical and ultrastructure comparison. Gynecol Oncol 1979, 8:34-43.
15. Moore KL: The pelvis and perineum. In: Clinically oriented anatomy (Edited by: Satterfield TS, Napora L, Lumpkin K). Baltimore, Williams & Williams 1992, 281-289.
16. Benjamin E, Law S, Bobrow LG: Intermediate filaments, cytokeratin and vimentin in ovarian sex cord-stromal tumours with correlative studies in adult and fetal ovaries. J Pathol 1987, 152:253-263.
17. Isola J, Kallioniemi OP, Korte JM, Wahlstrom T, Aine R, Helle M, Helin H: Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J Pathol 1990, 162:295-301.
18. Czernobilsky B, Moll R, Levy R, Franke WW: Co-expression of cytokeratin and vimentin filaments in mesothelial, granulosa and rete ovarii cells of the human ovary. Eur J Cell Biol 1985, 37:175-190.
19. Jindal SK, Ishii E, Letarte M, Vera S, Teerds K, Dorrington JH: Regulation of transforming growth factor-α gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biol Reprod 1995, 52:1027-1037.
20. Rodriguez GC, Berchuck A, Whitaker RS, Schlossman D, Clarke-Pearson DL, Bast RCJ: Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor. Am J Obstet Gynecol 1991, 164:745-750.
21. Bjersing L, Cajander S: Ovulation and the mechanism of follicle rupture. V. Ultrastructure of tunica albuginea and theca externa of rabbit graafian follicles prior to induced ovulation. Cell Tissue Res 1974, 153:15-30.
22. Ackerman RC, Murdoch WJ: Prostaglandin-induced apoptosis of ovarian surface epithelial cells. Prostaglandins 1993, 45:475-485
23. Osterholzer HO, Johnson JH, Nicosia SV: An autoradiographic study of rabbit ovarian surface epithelium before and after ovulation. Biol Reprod 1985, 33:729-738.
24. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC: Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001, 22:255-288.
25. Nicosia SV: The aging ovary. Med Clin North Am 1987, 71:1-9.
26. Hamilton TC: Ovarian cancer, Part I: Biology. Curr Probl Cancer 1992, 16:1-57.
27. Salazar H, Godwin AK, Daly MB, Laub PB, Hogan WM, Rosenblum N, Boente MP, Lynch HT, Hamilton TC: Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst 1996, 88:1810-1820.
28. Deligdisch L, Gil J: Characterization of ovarian dysplasia by interactive morphometry. Cancer 1989, 63:748-755.
29. Scully RE: Early de novo ovarian cancer and cancer developing in benign ovarian lesions. Int J Gynaecol Obstet 1995, 49(Suppl):S9-15.
30. Auersperg N, Siemens CH, Myrdal SE: Human ovarian surface epithelium in primary culture. In Vitro 1984, 20:743-755.
31. Adams AT, Auersperg N: Transformation of cultured rat ovarian surface epithelial cells by Kirsten murine sarcoma virus. Cancer Res 1981, 41:2063-2072.
32. Leung EH, Leung PC, Auersperg N: Differentiation and growth potential of human ovarian surface epithelial cells expressing temperature-sensitive SV40 T antigen. In Vitro Cell Dev Biol Anim 2001, 37:515-521.
33. Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A, Roskelley CD: E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 1999, 96:6249-6254.
34. Ong A, Maines-Bandiera SL, Roskelley CD, Auersperg N: An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int J Cancer 2000, 85:430-437.
35. Gregoire L, Rabah R, Schmelz EM, Munkarah A, Roberts PC, Lancaster WD: Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro. Clin Cancer Res 2001, 7:4280-4287.
36. Adams AT, Auersperg N: A cell line, ROSE 199, derived from normal rat ovarian surface epithelium. Exp Cell Biol 1985, 53:181-188.
37. Hoffman AG, Burghardt RC, Tilley R, Auersperg N: An in vitro model of ovarian epithelial carcinogenesis: changes in cell-cell communication and adhesion occuring during neoplastic progression. Int J Cancer 1993, 54:828-838.
38. Godwin AK, Testa JR, Handel LM, Liu Z, Vanderveer LA, Tracey PA, Hamilton TC: Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst 1992, 84:592-601.
39. Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, Tawfik O, Persons DL, Smith PG, Terranova PF: Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 2000, 21:585-591.
40. Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS, Varmus HE: Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 2002, 1:53-62.
41. Tonin PN, Hudson TJ, Rodier F, Bossolasco M, Lee PD, Novak J, Manderson EN, Provencher D, Mes-Masson AM: Microarray analysis of gene expression mirrors the biology of an ovarian cancer model. Oncogene 2001, 20:6617-6626.
42. Roberts D, Williams SJ, Cvetkovic D, Weinstein JK, Godwin AK, Johnson SW, Hamilton TC: Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium. DNA Cell Biol 2002, 21:11-19.
43. Ward BG, Wallace K: Localization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts. Cancer Res 1987, 47:4714-4718.
44. Hamilton TC, Young RC, Louie KG, Behrens BC, McKoy WM, Grotzinger KR, Ozols RF: Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. Cancer Res 1984, 44:5286-5290.
45. Massazza G, Tomasoni A, Lucchini V, Allavena P, Erba E, Colombo N, Mantovani A, D'Incalci M, Mangioni C, Giavazzi R: Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy. Int J Cancer 1989, 44:494-500.
46. Fu X, Hoffman RM: Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res 1993, 13:283-286.
47. Scully RE, Young RH, Clement PB: Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament Washington DC, Armed Forces Institute of Pathology 1996.
48. Fathalla MF: Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971, 2:163.
49. Whittemore AS, Harris R, Itnyre J: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer Collaborative Ovarian Cancer Group. Am J Epidemiol 1992, 136:1212-1220.
50. La Vecchia C, Franceschi S: Oral contraceptives and ovarian cancer. Eur J Cancer Prev 1999, 8:297-304.
51. Clow OL, Hurst PR, Fleming JS: Changes in the mouse ovarian surface epithelium with age and ovulation number. Mol Cell Endocrinol 2002, 191:105-111.
52. Cramer DW, Welch WR: Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983, 71:717-721.
53. Sell A, Bertelsen K, Andersen JE, Stroyer I, Panduro J: Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 1990, 37:367-373.
54. Chakravarti S, Collins WP, Forecast JD, Newton JR, Oram DH, Studd JW: Hormonal profiles after the menopause. Br Med J 1976, 2:784-787.
55. Zheng WX, Magid MS, Kramer EE, Chen YT: Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 1996, 148:47-53.
56. Konishi I, Kuroda H, Mandai M: Review: gonadotropins and development of ovarian cancer. Oncology 1999, 57(Suppl 2):45-48.
57. Osterholzer HO, Streibel EJ, Nicosia SV: Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. Biol Reprod 1985, 33:247-258.
58. Davies BR, Finnigan DS, Smith SK, Ponder BA: Administration of gonadotropins stimulates proliferation of normal mouse ovarian surface epithelium. Gynecol Endocrinol 1999, 13:75-81.
59. Schiffenbauer YS, Abramovitch R, Meir G, Nevo N, Holzinger M, Itin A, Keshet E, Neeman M: Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci U S A 1997, 94:13203-13208.
60. Biskind MS, Biskind GS: Development of tumors in the rat ovary after transplantation into the spleen. Proc Soc Exp Biol Med 1944, 55:176-179.
61. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A: Alpha-inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 1992, 360:313-319.
62. Nilson JH, Abbud RA, Keri RA, Quirk CC: Chronic hypersecretion of luteinizing hormone in transgenic mice disrupts both ovarian and pituitary function, with some effects modified by the genetic background. Recent Prog Horm Res 2000, 55:69-89.
63. Keri RA, Lozada KL, Abdul-Karim FW, Nadeau JH, Nilson JH: Luteinizing hormone induction of ovarian tumors: oligogenic differences between mouse strains dictates tumor disposition. Proc Natl Acad Sci USA 2000, 97:383-387.
64. Danilovich N, Roy I, Sairam MR: Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice. Endocrinology 2001, 142:3673-3684.
65. Gondos B: Surface epithelium of the developing ovary. Possible correlation with ovarian neoplasia. Am J Pathol 1975, 81:303-321.
66. Karlan BY, Jones J, Greenwald M, Lagasse LD: Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro. Am J Obstet Gynecol 1995, 173:97-104.
67. Lau KM, Mok SC, Ho SM: Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 1999, 96:5722-5727.
68. Hamilton TC, Davies P, Criffiths K: Steroid hormone receptor status of the normal and neoplastic ovarian surface germinal epithelium. In Factors regulating ovarian function (Edited by: Greenwald GS, Terranova PF). New York, Raven Press 1983, 81-85.
69. Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C: Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002, 288:334-341.
70. Murdoch WJ, Van Kirk EA: Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells. Mol Cell Endocrinol 2002, 186:61-67.
71. Silva EG, Tornos C, Deavers M, Kaisman K, Gray K, Gershenson D: Induction of epithelial neoplasms in the ovaries of guinea pigs by estrogenic stimulation. Gynecol Oncol 1998, 71:240-246.
72. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV: Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim 2000, 36:657-666.
73. Kang SK, Choi KC, Tai CJ, Auersperg N, Leung PC: Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells. Endocrinology 2001, 142:580-588.
74. Liu Y, Lin L, Zarnegar R: Modulation of hepatocyte growth factor gene expression by estrogen in mouse ovary. Mol Cell Endocrinol 1994, 104:173-181.
75. Ilekis JV, Connor JP, Prins GS, Ferrer K, Niederberger C, Scoccia B: Expression of epidermal growth factor and androgen receptors in ovarian cancer. Gynecol Oncol 1997, 66:250-254.
76. Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC, Comstock GW: Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995, 274:1926-1930.
77. Silva EG, Tornos C, Fritsche HAJ, el-Naggar A, Gray K, Ordonez NG, Luna M, Gershenson D: The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod Pathol 1997, 10:879-883.
78. Evangelou A, Jindal SK, Brown TJ, Letarte M: Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Cancer Res 2000, 60:929-935.
79. Mintz B, Russell ES: Gene-induced embryological modifications of primordial germ cells in the mouse. J Exp Zool 1957, 134:207-237.
80. Murphy ED: Hyperplastic and early neoplastic changes in the ovaries of mice after genic deletion of germ cells. J Natl Cancer Inst 1972, 48:1283-1295.
81. Murphy ED, Beamer WG: Plasma gonadotropin levels during early stages of ovarian tumorigenesis in mice of the Wx/Wv genotype. Cancer Res 1973, 33:721-723.
82. Ishimura K, Matsuda H, Tatsumi H, Fujita H, Terada N, Kitamura Y: Ultrastructural changes in the ovaries of Sl/Slt mutant mice, showing developmental deficiency of follicles and tubular adenomas. Arch Histol Jpn 1986, 49:379-389.
83. Duncan MK, Chada KK: Incidence of tubulostromal adenoma of the ovary in aged germ cell-deficient mice. J Comp Pathol 1993, 109:13-19.
84. Capen CC, Beamer WG, Tennent BJ, Stitzel KA: Mechanisms of hormone-mediated carcinogenesis of the ovary in mice. Mutat Res 1995, 333:143-151.
85. Tennent BJ, Beamer WG: Ovarian tumors not induced by irradiation and gonadotropins in hypogonadal (hpg) mice. Biol Reprod 1986, 34:751-760.
86. Blaakaer J, Baeksted M, Micic S, Albrectsen P, Rygaard J, Bock J: Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype. Biol Reprod 1995, 53:775-779.
87. Gertig DM, Hunter DJ, Cramer DW, Colditz GA, Speizer FE, Willett WC, Hankinson SE: Prospective study of talc use and ovarian cancer. J Natl Cancer Inst 2000, 92:249-252.
88. Hamilton TC, Fox H, Buckley CH, Henderson WJ, Griffiths K: Effects of talc on the rat ovary. Br J Exp Pathol 1984, 65:101-106.
89. Sims DE, Singh A, Donald A, Jarrell J, Villeneuve DC: Alteration of primate ovary surface epithelium by exposure to hexachlorobenzene: a quantitative study. Histol Histopathol 1991, 6:525-529.
90. Borgeest C, Symonds D, Mayer LP, Hoyer PB, Flaws JA: Methoxychlor may cause ovarian follicular atresia and proliferation of the ovarian epithelium in the mouse. Toxicol Sci 2002, 68:473-478.
91. Maronpot RR: Ovarian toxicity and carcinogenicity in eight recent National Toxicology Program studies. Environ Health Perspect 1987, 73:125-130.
92. Collins JJ, Montali RJ, Manus AG: Toxicological evaluation of 4-vinylcyclohexene. II. Induction of ovarian tumors in female B6C3F1 mice by chronic oral administration of 4-vinylcyclohexene. J Toxicol Environ Health 1987, 21:507-524.
93. Stoica G, Koestner A, Capen CC: Testicular (Sertoli's cell)-like tumors of the ovary induced by N-ethyl-N-nitrosourea (ENU) in rats. Vet Pathol 1985, 22:483-491.
94. Vanderhyden BC, Shaw TJ, Garson K, Tonary AM: Ovarian Carcinogenesis. In: The Ovary (Edited by: Leung PCK, Adashi EY). San Diego, Elsevier Science 2003, in press.
95. Flesken-Nikitin A, Choi K-C, Eng JP, Shmidt EN, Nikitin AY: Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res 2003, in press.
96. Aunoble B, Sanches R, Didier E, Bignon Y-J: Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int J Oncol 2000, 16:567-576.
97. Gras E, Pons C, Machin P, Matias-Guiu X, Prat J: Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: a molecular, immunohistochemical, and clinicopathologic study. Int J Gynecol Pathol 2001, 20:335-340.
98. Kananen K, Markkula M, Rainio E, Su JG, Hsueh AJ, Huhtaniemi IT: Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines. Mol Endocrinol 1995, 9:616-627.
99. Dutertre M, Gouedard L, Xavier F, Long WQ, di Clemente N, Picard JY, Rey R: Ovarian granulosa cell tumors express a functional membrane receptor for anti-Mullerian hormone in transgenic mice. Endocrinology 2001, 142:4040-4046.
100. Selvakumaran M, Bao R, Crijns AP, Connolly DC, Weinstein JK, Hamilton TC: Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element. Cancer Res 2001, 61:1291-1295.
101. Garson K, Macdonald E, Dube M, Bao R, Hamilton TC, Vanderhyden BC: Generation of tumors in transgenic mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1. J Soc Gynecol Investig 2003, 10:244-250.
102. Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC: Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 2003, 63:1389-1397.
103. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, Picard JY, Vigier B, Josso N, Cate R: Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol Endocrinol 1994, 8:1006-1020.
104. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, Grootegoed JA: Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995, 136:4951-4962.
105. Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge JW, de Winter JP, Uilenbroek JT, Karels B, Wilming LG, Meijers JH, et al.: A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development 1994, 120:189-197.
106. Teixeira J, He WW, Shah PC, Morikawa N, Lee MM, Catlin EA, Hudson PL, Wing J, Maclaughlin DT, Donahoe PK: Developmental expression of a candidate mullerian inhibiting substance type II receptor. Endocrinology 1996, 137:160-165.
107. Masiakos PT, MacLaughlin DT, Maheswaran S, Teixeira J, Fuller AF Jr, Shah PC, Kehas DJ, Kenneally MK, Dombkowski DM, Ha TU, Preffer FI, Donahoe PK: Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. Clin Cancer Res 1999, 5:3488-3499.